Cargando…
Immunomodulating Therapy by Picibanil-based Imiquimod and Virotherapy for Advanced Uterine Cancer after Laparoscopic Surgery
This is a case report of a uterine cancer with the International Federation of Gynecology and Obstetrics staging 3c2 with the initial clinical presentation of postmenopausal vaginal bleeding in August 2015. Endometrium biopsy showed invasive nests of poorly differentiated grade 3 endometrioid adenoc...
Autores principales: | Peng, Hsiu-Huei, Huang, Yi-Ting, Cheng, Zhuo-Xin, Lee, Chyi-Long, Lin, Cheng-Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384025/ https://www.ncbi.nlm.nih.gov/pubmed/34485069 http://dx.doi.org/10.4103/GMIT.GMIT_153_20 |
Ejemplares similares
-
Picibanil (OK-432) in the treatment of head and neck lymphangiomas in children
por: Rebuffini, Elena, et al.
Publicado: (2012) -
Immunomodulation by imiquimod in patients with high-risk primary melanoma
por: Narayan, Rupa, et al.
Publicado: (2011) -
Treatment of lymphangiomas by means of sclerotherapy with OK-432 (Picibanil®) is safe and effective – A retrospective case series
por: Fasching, G., et al.
Publicado: (2022) -
Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022) -
Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
por: Panek, Wojciech K., et al.
Publicado: (2017)